March 18th, 2015
•Here, we describe a robust protocol for human cardiomyocyte derivation that combines small molecule-modulated cardiac differentiation and glucose deprivation-mediated cardiomyocyte purification, enabling production of purified cardiomyocytes for the purposes of cardiovascular disease modeling and drug screening.
Related Videos
Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells Video (Video) | JoVE
Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells Video (Video) | JoVE
Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2 Video (Video) | JoVE
Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol Video (Video) | JoVE
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells Video (Video) | JoVE
Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells Video (Video) | JoVE
Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix Video (Video) | JoVE
Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells Video (Video) | JoVE
Derivation and Differentiation of Canine Ovarian Mesenchymal Stem Cells Video (Video) | JoVE
Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved